NCT05352737View on ClinicalTrials.gov

Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

June 24, 2022

Study Completion Date

June 24, 2022

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

methylmalonic acid testing

Trial Locations (1)

3000

Lab of Experimental Oncology, Leuven

All Listed Sponsors
lead

KU Leuven

OTHER

NCT05352737 - Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer | Biotech Hunter | Biotech Hunter